INCY stock news · Incyte Corporation
Get alerts for INCY
Follow Incyte Corporation (INCY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for INCYFree on the App Store and Google Play, or on the web.
INCYTE CORP: Other Events (INCY)
Bad for INCYIncyte canceled its planned Phase 3 study of INCB123667 for ovarian cancer. This removes a planned path to test the drug, despite unchanged financial forecasts and long-term outlook.